As a vital carrier in modern pharmaceutical formulations, the evolution of empty hard capsules reflects the advancement of pharmaceutics from traditional to modern practices. This seemingly simple pharmaceutical excipient not only addresses issues such as the bitterness and irritancy of drugs during administration but has also propelled the standardization and scale of the pharmaceutical industry, becoming an indispensable component in drug dosage forms.
The prototype of capsules can be traced back to ancient Egypt and Greece, where people used animal intestines or beeswax to wrap medicines to mask unpleasant odors or facilitate swallowing. However, the true empty hard capsule was born in mid-19th century France. In 1834, Parisian pharmacist Achille Colas invented a method for manually producing gelatin capsules by dipping molds to form capsule shells, achieving standardized drug encapsulation for the first time. This invention quickly spread across Europe and reached the United States by the late 19th century, giving rise to the industrialization of capsule production.
In the early 20th century, with the rise of the pharmaceutical industry, the manufacturing technology of empty hard capsules underwent a major breakthrough. In 1912, American pharmacist Robert Paul Scherer invented an automatic capsule manufacturing machine, enabling continuous production and significantly improving both efficiency and product consistency. During this period, gelatin became widely used as the primary capsule material, and capsule sizes were gradually standardized, forming the now-common size system from 00 to 5.
After World War II, with the expansion of the global pharmaceutical market, the empty hard capsule industry entered a period of rapid growth. In the 1960s, the advent of enteric-coated capsules solved the problem of drugs being easily destroyed in the stomach. In the 1970s, vegetable capsules emerged to meet the needs of vegetarians and individuals with specific religious beliefs. Entering the 21st century, the application of new polymer materials has driven the development of functional capsules, such as sustained-release capsules and targeted-release capsules, significantly enhancing therapeutic outcomes.
At the same time, production processes evolved from the traditional dipping method to the more efficient dropping method, increasing production efficiency dozens of times over. Modern capsule production lines now feature fully automated control, with product quality meeting pharmaceutical-grade standards. Global annual capsule production has surpassed one trillion pieces, with China, the United States, and Japan being the leading producers.
Today, empty hard capsules have evolved from a simple drug delivery tool into a high-tech drug delivery system. They not only carry active pharmaceutical ingredients but also embody humanity's relentless pursuit of precision in drug administration. With breakthroughs in 3D printing technology, nanomaterials, and smart responsive materials, empty hard capsules are set to shine even brighter in the fields of personalized medicine, gene therapy, and targeted drug delivery, continuing to write a brilliant chapter in the advancement of pharmaceutical science and technology. If there is any demands on empty capsules, welcome to contact KornnacCaps.
